Human papillomavirus infection
Current global scenario of disease burden and prevention strategies
Keywords:
HPV, cervical cancer, HPV vaccine, HPV epidemiologyAbstract
In the past decade, cervical cancer has increased alarmingly in different parts of the world especially in developing regions. Cervical cancer is caused by persistent infection with high-risk HPV. Interestingly, HPV infection is associated with other cancers also besides cervical carcinoma. Therefore, a proper understanding of epidemiology, pathophysiology,and treatment and prevention strategy is required to combat this commonly occurring cancer. To eliminate cervical cancer from the global map the only strategy is rigorous vaccination in school-going teenage girls. The WHO wants to eliminate HPV by 2030. Its goal is to vaccinate 90% of females by 2025. However, proper awareness and government initiatives are far behind the required drive. Moreover, the low use of cervical cancer screening techniques like Pap smear and visual inspection with acetic acid hindered HPV infection and cervical cancer control in affected countries. In addition, we try to describe the whole pathological cycle of HPV in humans with prominent risk factors that can be a key to control the incidence of HPV-associated cancers. Finally, we showed the significance of the only available strategy to prevent HPV infection- i.e. vaccination.
Downloads
References
Aswathy, S., Reshma, J., Avani, D., 2015. Epidemiology of cervical cancer with special focus on India. IJWH 405. https://doi.org/10.2147/IJWH.S50001
Basu, P., Malvi, S.G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P.O., Poli, U.R.R., Shah, A., Zomawia, E., Pimple, S., Jayant, K., Hingmire, S., Chiwate, A., Divate, U., Vashist, S., Mishra, G., Jadhav, R., Siddiqi, M., Sankaran, S., Prabhu, P.R., Kannan, T.P.R.A., Varghese, R., Shastri, S.S., Anantharaman, D., Gheit, T., Tommasino, M., Sauvaget, C., Pillai, M.R., Sankaranarayanan, R., 2021. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study. The Lancet Oncology 22, 1518–1529. https://doi.org/10.1016/S1470-2045(21)00453-8
Basukala, O., Banks, L., 2021. The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis. Viruses 13, 1892. https://doi.org/10.3390/v13101892
Bates, J.E., Steuer, C.E., 2022. HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future? Curr. Treat. Options in Oncol. 23, 325–332. https://doi.org/10.1007/s11864-022-00950-8
Cab-Sánchez, B.G., Hernández-Solís, S.E., Rueda-Gordillo, F., Conde-Ferráez, L., Gómez-Carballo, J.G., González-Losa, M. del R., 2017. Epidemiología de la infección oral por VPH en sujetos jóvenes sanos. Rev. chil. infectol. 34, 557–562. https://doi.org/10.4067/S0716-10182017000600557
Chen, L., Riaz, N., Lee, N., McBride, S., 2021. Current considerations for radiotherapy in HPV‐associated head and neck cancer. J Surg Oncol 124, 945–951. https://doi.org/10.1002/jso.26689
Chew, K.T., Kampan, N., Shafiee, M.N., 2021. Perception and knowledge of human papillomavirus (HPV) vaccine for cervical cancer prevention among fully vaccinated female university students in the era of HPV vaccination: a cross-sectional study. BMJ Open 11, e047479. https://doi.org/10.1136/bmjopen-2020-047479
Cho, H.-W., Min, K.-J., Kwon, S.-H., Kim, K., Kim, S., Seong, S.J., Song, Y.J., Lee, K.H., Lee, S.-W., Lee, J.-W., Ju, W., Kim, Y.T., Lee, J.K., 2021. Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines. J Gynecol Oncol 32, e94. https://doi.org/10.3802/jgo.2021.32.e94
Choi, Y., Loutfy, M., Remis, R.S., Liu, J., Rebbapragada, A., Huibner, S., Brunetta, J., Smith, G., Reko, T., Halpenny, R., Kaul, R., Grennan, T., 2021. HPV genotyping and risk factors for anal high-risk HPV infection in men who have sex with men from Toronto, Canada. Sci Rep 11, 4779. https://doi.org/10.1038/s41598-021-84079-y
Citro, S., Miccolo, C., Medda, A., Ghiani, L., Tagliabue, M., Ansarin, M., Chiocca, S., 2022. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer. J Exp Clin Cancer Res 41, 59. https://doi.org/10.1186/s13046-022-02258-9
Cosper, P.F., Bradley, S., Luo, Q., Kimple, R.J., 2021. Biology of HPV Mediated Carcinogenesis and Tumor Progression. Seminars in Radiation Oncology 31, 265–273. https://doi.org/10.1016/j.semradonc.2021.02.006
de Sanjosé, S., Brotons, M., Pavón, M.A., 2018. The natural history of human papillomavirus infection. Best Practice & Research Clinical Obstetrics & Gynaecology 47, 2–13. https://doi.org/10.1016/j.bpobgyn.2017.08.015
Ding, L., Liu, C., Zhou, Q., Feng, M., Wang, J., 2019. Association of estradiol and HPV/HPV16 infection with the occurrence of cervical squamous cell carcinoma. Oncol Lett. https://doi.org/10.3892/ol.2019.10005
Dorji, T., Tshomo, U., Gyamtsho, S., Tamang, S.T., Wangmo, S., Pongpirul, K., 2022. Gender‐neutral HPV elimination, cervical cancer screening, and treatment: Experience from Bhutan. Intl J Gynecology & Obste 156, 425–429. https://doi.org/10.1002/ijgo.13728
Feletto, M., Sharkey, A.B., 2019. Broadening the perspective on gender equity in immunization: The unique contributions of Human Papillomavirus vaccination. Vaccine 37, 5920–5922. https://doi.org/10.1016/j.vaccine.2019.08.035
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D.M., Piñeros, M., Znaor, A., Bray, F., 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer 144, 1941–1953. https://doi.org/10.1002/ijc.31937
Fogarasi, A.I., Benczik, M., Moravcsik-Kornyicki, Á., Kocsis, A., Gyulai, A., Kósa, Z., 2022. The Prevalence of High-Risk Human Papillomavirus in Hungary—A Geographically Representative, Cross-Sectional Study. Pathol. Oncol. Res. 28, 1610424. https://doi.org/10.3389/pore.2022.1610424
Grace, D., Gaspar, M., Paquette, R., Rosenes, R., Burchell, A.N., Grennan, T., Salit, I.E., 2018. HIV-positive gay men’s knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study. PLoS ONE 13, e0207953. https://doi.org/10.1371/journal.pone.0207953
Gupta, S.M., Mania-Pramanik, J., 2019. RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. J Biomed Sci 26, 28. https://doi.org/10.1186/s12929-019-0520-2
Hooi, D.J., Lissenberg-Witte, B.I., Kenter, G., de Koning, M.N.C., Gomes Bravio, I., Ardts, K., Kleinmoedig, S., Benita, E., Pinedo, H.M., Berkhof, J., Quint, W.G.V., Meijer, C.J.L.M., 2018. Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao. PLoS ONE 13, e0199624. https://doi.org/10.1371/journal.pone.0199624
Iliadou, M., Sahini, K., Sakellari, E., Daglas, M., Orovou, E., Iatrakis, G., Antoniou, E., 2021. What do Young People Think About HPV and HPV Vaccination? The Role of Health Education Interventions and Health Professionals. Mater Sociomed 33, 219. https://doi.org/10.5455/msm.2021.33.219-224
Jose, L., Gilson, T., Androphy, E.J., DeSmet, M., 2021. Regulation of the Human Papillomavirus Lifecyle through Post-Translational Modifications of the Viral E2 Protein. Pathogens 10, 793. https://doi.org/10.3390/pathogens10070793
Kahn, J.A., Brown, D.R., Ding, L., Widdice, L.E., Shew, M.L., Glynn, S., Bernstein, D.I., 2012. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 130, e249-256. https://doi.org/10.1542/peds.2011-3587
Kamolratanakul, S., Pitisuttithum, P., 2021. Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Vaccines 9, 1413. https://doi.org/10.3390/vaccines9121413
Keller, K., Ramos-Cartagena, J.M., Guiot, H.M., Muñoz, C., Rodríguez, Y., Colón-López, V., Deshmukh, A.A., Tirado-Gómez, M., Ortiz, A.P., 2022. Association of smoking with anal high-risk HPV infection and histologically confirmed anal high-grade squamous intraepithelial lesions among a clinic-based population in Puerto Rico. Cancer Treatment and Research Communications 30, 100503. https://doi.org/10.1016/j.ctarc.2021.100503
Lekoane, K.M.B., Kuupiel, D., Mashamba-Thompson, T.P., Ginindza, T.G., 2020. The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review. Syst Rev 9, 88. https://doi.org/10.1186/s13643-020-01354-1
Lin, S., Gao, K., Gu, S., You, L., Qian, S., Tang, M., Wang, J., Chen, K., Jin, M., 2021. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer 127, 4030–4039. https://doi.org/10.1002/cncr.33795
Liu, G., Mugo, N.R., Bayer, C., Rao, D.W., Onono, M., Mgodi, N.M., Chirenje, Z.M., Njoroge, B.W., Tan, N., Bukusi, E.A., Barnabas, R.V., 2022. Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence. eClinicalMedicine 45, 101306. https://doi.org/10.1016/j.eclinm.2022.101306
Matsumura, N., Tsunoda, I., 2022. Scientific evaluation of alleged findings in HPV vaccines: Molecular mimicry and mouse models of vaccine‐induced disease. Cancer Science cas.15482. https://doi.org/10.1111/cas.15482
Narváez, F. A. S., & Castro, E. I. M. (2021). Energy planning with renewable energy sources. International Journal of Physical Sciences and Engineering, 5(3), 44–51. https://doi.org/10.53730/ijpse.v5n3.2941
Nash, D., Chan, C., Horowitz, D., Vlahov, D., 2007. Barriers And Missed Opportunities in Breast And Cervical Cancer Screening among Women Aged 50 And Over, New York City, 2002. Journal of Women’s Health 16, 46–56. https://doi.org/10.1089/jwh.2006.0079
Palefsky, J.M., Lensing, S.Y., Belzer, M., Lee, J., Gaur, A.H., Mayer, K., Futterman, D., Stier, E.A., Paul, M.E., Chiao, E.Y., Reirden, D., Goldstone, S.E., Tirado, M., Cachay, E.R., Barroso, L.F., Da Costa, M., Darragh, T.M., Rudy, B.J., Wilson, C.M., Kahn, J.A., 2021. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus. Clinical Infectious Diseases 73, 1388–1396. https://doi.org/10.1093/cid/ciab434
Roman, B.R., Aragones, A., 2021. Epidemiology and incidence of HPV‐related cancers of the head and neck. J Surg Oncol 124, 920–922. https://doi.org/10.1002/jso.26687
Schwendener, C.L., Kiener, L.M., Jafflin, K., Rouached, S., Juillerat, A., Meier, V., Schärli Maurer, S., Muggli, F., Gültekin, N., Baumann, A., Debergh, M., Gruillot, C., Huber, B., Merten, S., Buhl, A., Deml, M.J., Tarr, P.E., 2022. HPV vaccine awareness, knowledge and information sources among youth in Switzerland: a mixed methods study. BMJ Open 12, e054419. https://doi.org/10.1136/bmjopen-2021-054419
Scott-Wittenborn, N., Fakhry, C., 2021. Epidemiology of HPV Related Malignancies. Seminars in Radiation Oncology 31, 286–296. https://doi.org/10.1016/j.semradonc.2021.04.001
Siegler, E., Goldberg, Y., Siegler, Y., Shaked-Mishan, P., Mazareb, S., Kugelman, N., Mackuli, L., Sabo, E., Lavie, O., Segev, Y., 2021. The Association Between Clearance of Human Papillomavirus After Conization for Cervical Cancer and Absence of Cancer. J Low Genit Tract Dis 25, 276–280. https://doi.org/10.1097/LGT.0000000000000622
Slatvinsky, M., Bondarenko, I., Ovcharenko, A., Stovba, T., & Tkachenko, T. (2022). COVID-19 pandemic influence on global business environment. International Journal of Health Sciences, 6(1), 277–290. https://doi.org/10.53730/ijhs.v6n1.4069
Small, W., Bacon, M.A., Bajaj, A., Chuang, L.T., Fisher, B.J., Harkenrider, M.M., Jhingran, A., Kitchener, H.C., Mileshkin, L.R., Viswanathan, A.N., Gaffney, D.K., 2017. Cervical cancer: A global health crisis: Cervical Cancer: A Global Health Crisis. Cancer 123, 2404–2412. https://doi.org/10.1002/cncr.30667
Steele, L.S., Ross, L.E., Dobinson, C., Veldhuizen, S., Tinmouth, J.M., 2009. Women’s Sexual Orientation and Health: Results from a Canadian Population-Based Survey. Women & Health 49, 353–367. https://doi.org/10.1080/03630240903238685
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Syrjänen, S., Shabalova, I.P., Petrovichev, N., Kozachenko, V.P., Zakharova, T., Pajanidi, J., Podistov, J.I., Chemeris, G., Sozaeva, L.G., Lipova, E.V., Tsidaeva, I., Ivanchenko, O.G., Pshepurko, A.A., Zakharenko, S., Nerovjna, R., Kljukina, L.B., Erokhina, O.A., Branovskaja, M.F., Nikitina, M., Grunberga, V., Grunberg, A., Juschenko, A., Tosi, P., Cintorino, M., Santopietro, R., Syrjänen, K.J., 2002. Human Papillomavirus Testing and Conventional Pap Smear Cytology as Optional Screening Tools of Women at Different Risks for Cervical Cancer in the Countries of the Former Soviet Union: Journal of Lower Genital Tract Disease 6, 97–110. https://doi.org/10.1097/00128360-200204000-00006
Tagne Simo, R., Kiafon, F.B., Nangue, C., Goura, A.P., Ebune, J.L., Usani, M.C., Nwabo Kamdje, A.H., Seke Etet, P.F., Telefo, P.B., 2021. Influence of HIV infection on the distribution of high-risk HPV types among women with cervical precancerous lesions in Yaounde, Cameroon. International Journal of Infectious Diseases 110, 426–432. https://doi.org/10.1016/j.ijid.2021.07.059
Tagne Simo, Richard, Djoko Nono, A.G., Fogang Dongmo, H.P., Seke Etet, P.F., Fonyuy, B.K., Kamdje, A.H.N., Yanou, N.N., Telefo, P.B., 2021. Prevalence of precancerous cervical lesions and high-risk human papillomavirus types in Yaounde, Cameroon. J Infect Dev Ctries 15, 1339–1345. https://doi.org/10.3855/jidc.15218
Thapa, N., Maharjan, M., Shrestha, G., Maharjan, N., Petrini, M.A., Zuo, N., He, C., Yang, J., Xu, M., Ge, C., Song, Z., Cai, H., 2018. Prevalence and type-specific distribution of human papillomavirus infection among women in mid-western rural, Nepal- A population-based study. BMC Infect Dis 18, 338. https://doi.org/10.1186/s12879-018-3175-9
Tomljenovic, L., Shaw, C.A., 2012. Too Fast or Not Too Fast: The FDA’s Approval of Merck’s HPV Vaccine Gardasil. J. Law. Med. Ethics 40, 673–681. https://doi.org/10.1111/j.1748-720X.2012.00698.x
Tounkara, F.K., Téguété, I., Guédou, F.A., Goma-Matsétsé, E., Koné, A., Béhanzin, L., Traoré, S., Aza-Gnandji, M., Keita, B., Guenoun, J., Coutlée, F., Alary, M., 2020. Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa. PLoS ONE 15, e0242711. https://doi.org/10.1371/journal.pone.0242711
Trujillo-Cirilo, L., Torres-Corioriles, E.I., Rangel-Corona, R., Corona-Ortega, M.T., Weiss-Steider, B., 2021. Evidence that the viral oncoproteins E6 and E7 of HPV induce the expression of a functional IL-2R on cervical cancer cells. Cytokine 148, 155592. https://doi.org/10.1016/j.cyto.2021.155592
Vanajothi, R., Srikanth, N., Vijayakumar, R., Palanisamy, M., Bhavaniramya, S., Premkumar, K., 2022. HPV-mediated Cervical Cancer: A Systematic Review on ImmunologicalBasis, Molecular Biology, and Immune Evasion Mechanisms. CDT 23, 782–801. https://doi.org/10.2174/1389450123666211221160632
Wei, F., Gaisa, M.M., D’Souza, G., Xia, N., Giuliano, A.R., Hawes, S.E., Gao, L., Cheng, S.-H., Donà, M.G., Goldstone, S.E., Schim van der Loeff, M.F., Neukam, K., Meites, E., Poynten, I.M., Dai, J., Combes, J.-D., Wieland, U., Burgos, J., Wilkin, T.J., Hernandez, A.L., Iribarren Díaz, M., Hidalgo-Tenorio, C., Valencia Arredondo, J.J., Yunihastuti, E., Etienney, I., Ferré, V.M., Zou, H., Segondy, M., Chinyowa, S., Alberts, C.J., Clifford, G.M., 2021. Epidemiology of anal human papillomavirus infection and high-grade squamous intraepithelial lesions in 29 900 men according to HIV status, sexuality, and age: a collaborative pooled analysis of 64 studies. The Lancet HIV 8, e531–e543. https://doi.org/10.1016/S2352-3018(21)00108-9
Wu, E.-Q., Liu, B., Cui, J.-F., Chen, W., Wang, J.-B., Lu, L., Niyazi, M., Zhao, C., Ren, S.-D., Li, C.-Q., Gong, X.-Z., Smith, J.S., Belinson, J.L., Liaw, K.-L., Velicer, C., Qiao, Y.-L., 2013. Prevalence of type-specific human papillomavirus and pap results in Chinese women: a multi-center, population-based cross-sectional study. Cancer Causes Control 24, 795–803. https://doi.org/10.1007/s10552-013-0162-8
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
